Search Results - "Scheel, Birgit"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study.

    Authors: Kübler, Hubert Scheel, Birgit Gnad-Vogt, Ulrike et al.

    Source: Journal for ImmunoTherapy of Cancer. 2015, Vol. 3 Issue 1, p1-14. 14p.

    Save to List
  2. 2

    Characterization of the ribonuclease activity on the skin surface.

    Authors: Probst, Jochen Brechtel, Sonja Scheel, Birgit et al.

    Source: Genetic Vaccines & Therapy. 2006, Vol. 4, p4-9. 9p. 4 Diagrams, 2 Graphs.

    PDF Full Text
    Save to List
  3. 3

    A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.

    Authors: Sebastian, Martin Schröder, Andreas Scheel, Birgit et al.

    Source: Cancer Immunology, Immunotherapy. May2019, Vol. 68 Issue 5, p799-812. 14p.

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    This result is not displayed to guests.

    Save to List
  5. 5

    Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer.

    Authors: Sebastian, Martin Papachristofilou, Alexandros Weiss, Christian et al.

    Source: BMC Cancer. 10/6/2014, Vol. 14, p1-10. 10p. 1 Diagram, 3 Charts.

    PDF Full Text
    Save to List
  6. 6

    CO-TRANSFECTION OF MESSENGER RNA AND siRNA AS A METHOD TO STUDY THE EFFICIENCY OF siRNA.

    Authors: Mutzke*, Thorsten Schubkegel*, Gudrun Teufel, Regina et al.

    Source: Nucleosides, Nucleotides & Nucleic Acids. Feb2005, Vol. 24 Issue 2, p147-152. 6p.

    HTML Full Text PDF Full Text
    Save to List
  7. 7

    Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas.

    Authors: Carralot, Jean-Philippe Weide, Benjamin Schoor, Oliver et al.

    Source: Genetic Vaccines & Therapy. 2005, Vol. 3, p6-10. 10p. 2 Charts, 1 Graph.

    PDF Full Text
    Save to List
  8. 8

    Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.

    Authors: Papachristofilou, Alexandros Hipp, Madeleine M. Klinkhardt, Ute et al.

    Source: Journal for ImmunoTherapy of Cancer. 12/1/2019, Vol. 7 Issue 1, p1-14. 14p.

    Save to List
  9. 9

    Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.

    Authors: Hong, Henoch S. Koch, Sven D. Scheel, Birgit et al.

    Source: OncoImmunology. 2016, Vol. 5 Issue 12, p1-1. 1p.

    PDF Full Text
    Save to List
  10. 10

    A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile.

    Authors: Heidenreich R Jasny E Kowalczyk A et al.

    Source: International journal of cancer [Int J Cancer] 2015 Jul 15; Vol. 137 (2), pp. 372-84. Date of Electronic Publication: 2015 Jan 08.

    Publication Type: Journal Article

    Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  11. 11

    A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines.

    Authors: Kallen KJ Heidenreich R Schnee M et al.

    Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2013 Oct; Vol. 9 (10), pp. 2263-76. Date of Electronic Publication: 2013 Jun 04.

    Publication Type: Journal Article; Review

    Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

    Save to List
  12. 12

    Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.

    Authors: Weide B Pascolo S Scheel B et al.

    Source: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2009 Jun; Vol. 32 (5), pp. 498-507.

    Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE

    Save to List
  13. 13

    Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.

    Authors: Weide B Carralot JP Reese A et al.

    Source: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2008 Feb-Mar; Vol. 31 (2), pp. 180-8.

    Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Print ISSN: 1524-9557 (Print) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE

    Save to List
  14. 14

    Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA.

    Authors: Scheel B Aulwurm S Probst J et al.

    Source: European journal of immunology [Eur J Immunol] 2006 Oct; Vol. 36 (10), pp. 2807-16.

    Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print Cited Medium: Print ISSN: 0014-2980 (Print) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE

    Save to List
  15. 15

    Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.

    Authors: Scheel B Teufel R Probst J et al.

    Source: European journal of immunology [Eur J Immunol] 2005 May; Vol. 35 (5), pp. 1557-66.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print Cited Medium: Print ISSN: 0014-2980 (Print) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE

    Save to List
  16. 16

    Immunostimulating capacities of stabilized RNA molecules.

    Authors: Scheel B Braedel S Probst J et al.

    Source: European journal of immunology [Eur J Immunol] 2004 Feb; Vol. 34 (2), pp. 537-47.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print Cited Medium: Print ISSN: 0014-2980 (Print) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE

    Save to List

Search Tools: